ClinicalTrials.Veeva

Menu

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

A

Acibadem University

Status

Completed

Conditions

The Prevalance of HMPV After COVID-19 Pandemic
The Importance of Accurate Diagnosis for HPMV

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT06309212
2023-20/687

Details and patient eligibility

About

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Full description

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Enrollment

2,197 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults >18 years
  • Patients with acute respiratory tract infection symptoms
  • Patients who underwent multiplex PCR testing for respiratory viruses

Exclusion criteria

  • Patients for whom no respiratory viral panel test was conducted

Trial design

2,197 participants in 2 patient groups

Pre-COVID period
Description:
January 2016 to January 2020
Treatment:
Other: Observation
Post-COVID period
Description:
January 2021 to September 2023
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems